As a federal appeals court in Chicago prepares to hear arguments later this month on the question of whether a drug company should bear responsibility for the effects of a generic equivalent medication they did not make or sell, pharmaceutical company GlaxoSmithKline has asked the judges to lend weight to a West Virginia Supreme Court delivered in recent days, which declared using drug warning labels to hold innovators liable for harm caused by a generic copy of their product would “sever the connection between risk and reward,” both raising prices and reducing innovation.
Judges with the U.S. Seventh Circuit Court of Appeals upheld a federal judge’s rejection of arguments that the Federal Housing Finance Agency undercut Fannie Mae and Freddie Mac investors by giving the U.S. Treasury too much authority when it was trying to save the home-lending behemoths.
Saying a “trifling loss” is still a loss under state consumer protection laws, a federal appeals panel has reopened the book on a potential class action lawsuit against Barnes & Noble over a 2012 data breach that cost customers some time and money in protecting themselves from potential identity theft, and which the appellate judges took care to note also victimized the chain of big box bookstores.
Dunkin' Donuts will need to try again to poke holes in a lawsuit claiming it deceived consumers about how much blueberry is actually in a blueberry donut, after a Chicago federal judge refused to toss the class action.
A federal judge has placed on hold the city of Chicago’s lawsuit accusing the makers of prescription painkillers like Oxycontin and Percocet – so-called “opioids” – of falsely marketing their drugs to doctors. defrauding City Hall and other employee health plan administrators, while giving time for a panel of federal judges to decide if the action should be consolidated with other similar lawsuits, brought by cities and others, now pending in other jurisdictions.
While their competitor AbbVie seeks to undo jury verdicts worth nearly $290 million over testosterone replacement therapy drugs, drugmaker Auxilium has received a clean bill from a jury in its first court test over claims it and other similar drugmakers should be made to pay for alleged misleading marketing that led men to take the drugs, and suffered heart attacks as a result.
While federal law bars the city of Chicago and other local governments from slapping taxes on homes acquired by federal home mortgage lending giants Fannie Mae and Freddie Mac, the law does nothing to stop such cities from merely passing on those tax bills to the people who later buy the property from Fannie or Freddie, a federal appeals panel says.
After two federal juries delivered $140 million verdicts against AbbVie, competing drugmaker Auxilium will be headed to trial over claims its testosterone replacement therapy drug Testim caused heart attacks in men who took the drug to treat “off-label” conditions, spurred by what plaintiffs alleged was misleading marketing from drugmakers.
A federal judge has dismissed an attempt by customers of Barnes & Noble to sue the bookseller over a 2012 data breach they say exposed them to an increased risk of identity theft.
The city of Chicago should not be allowed to sidestep laws barring cities from collecting taxes on real estate sold by federal mortgage lending giants Fannie Mae and Freddie Mac by simply passing on the tax bills to those buying the properties from Fannie and Freddie, a federal judge has ruled.
Fannie Mae, the federally-controlled largest provider of funding for mortgage loans in the country, has sued the city of Chicago in federal court to ask a judge to halt the city’s efforts to collect real estate transfer taxes on the residential properties the agency sells. On Oct. 15, the Federal National Mortgage Association, commonly known as Fannie Mae, and the Federal Housing Finance Agency, the federal agency which oversees Fannie, filed its complaint in federal court in Chicago against
